NDC 67296-1933
Buprenorphine and NaloxoneSublingual Film 2 mg / 8 mg film
On the label: RedPharm Drug. Inc.. It's repackaged: RedPharm Drug. Inc. rebottles it from Alvogen Inc.'s NDC 47781-357.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Alvogen Inc. names for other drugs.
Repackaging site
- RedPharm Drug, Eden Prairie, MN, United States · repackages it
Recalls
- Feb 26, 2021 · Class II · Alvogen, Inc
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Lots: Lot #: 36924, Exp 6/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buprenorphine and Naloxone: every company that makes it
- Form
- film, buccal; sublingual
- Strength
- 2 mg / 8 mg
- Approval
- ANDA ANDA205954
- On the market since
- Feb 11, 2019
- Package NDCs
67296-1933-6- Official label
- DailyMed (National Library of Medicine), updated Aug 12, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?